KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)

Medpace Holdings' Non-Current Deffered Revenue history spans 2 years, with the latest figure at $4.0 million for Q3 2018.

  • For Q3 2018, Non-Current Deffered Revenue fell 81.14% year-over-year to $4.0 million; the TTM value through Sep 2018 reached $4.0 million, down 81.14%, while the annual FY2017 figure was $11.5 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue reached $4.0 million in Q3 2018 per MEDP's latest filing, down from $11.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $21.4 million in Q2 2017 to a low of $4.0 million in Q3 2018.